Efficacy and Safety of BCD-100 (Anti-PD-1) in Combination With Platinum-Based Chemotherapy as First Line Treatment in Patients With Advanced Non-Squamous NSCLC

NCT03912389 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

292

Enrollment

INDUSTRY

Sponsor class

Conditions

Non-Squamous Non-Small Cell Neoplasm of Lung

Interventions

BIOLOGICAL: BCD-100
DRUG: Pemetrexed
DRUG: Cisplatin (or carboplatin)
OTHER: Placebo

Sponsor

Biocad